These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 19215002

  • 1. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors.
    Pérez-Martínez A, Leung W, Muñoz E, Iyengar R, Ramírez M, Vicario JL, Lassaletta A, Sevilla J, González-Vicent M, Madero L, Díaz-Pérez MA.
    Pediatr Blood Cancer; 2009 Jul; 53(1):120-4. PubMed ID: 19215002
    [Abstract] [Full Text] [Related]

  • 2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 3. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.
    Lang P, Pfeiffer M, Müller I, Schumm M, Ebinger M, Koscielniak E, Feuchtinger T, Föll J, Martin D, Handgretinger R.
    Klin Padiatr; 2006 Apr; 218(6):321-6. PubMed ID: 17080334
    [Abstract] [Full Text] [Related]

  • 4. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C, ARS2000 FRM and FGM group.
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [Abstract] [Full Text] [Related]

  • 5. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
    Moroso V, van der Meer A, Tilanus HW, Kazemier G, van der Laan LJ, Metselaar HJ, Joosten I, Kwekkeboom J.
    Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
    [Abstract] [Full Text] [Related]

  • 6. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
    Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E, International Histocompatibility Working Group.
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
    [Abstract] [Full Text] [Related]

  • 7. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
    Ruggeri L, Mancusi A, Burchielli E, Perruccio K, Aversa F, Martelli MF, Velardi A.
    Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
    [Abstract] [Full Text] [Related]

  • 8. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW.
    Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
    [Abstract] [Full Text] [Related]

  • 9. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ, He J, Chen ZX, Wu DP, Yao L, Yuan XN, Cen JN, Qiu QC, Di WY, Zhang H, Zhang J, Zhou XH, Xu HX.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [Abstract] [Full Text] [Related]

  • 10. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY, Huang XJ, Liu KY, Xu LP, Liu DH.
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [Abstract] [Full Text] [Related]

  • 11. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Sobecks RM, Ball EJ, Askar M, Theil KS, Rybicki LA, Thomas D, Brown S, Kalaycio M, Andresen S, Pohlman B, Dean R, Sweetenham J, Macklis R, Bernhard L, Cherni K, Copelan E, Maciejewski JP, Bolwell BJ.
    Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
    [Abstract] [Full Text] [Related]

  • 12. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
    La Nasa G, Littera R, Locatelli F, Giardini C, Ventrella A, Mulargia M, Vacca A, Orrù N, Orrù S, Piras E, Giustolisi G, Lisini D, Nesci S, Caocci G, Carcassi C.
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
    [Abstract] [Full Text] [Related]

  • 13. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
    Verheyden S, Schots R, Duquet W, Demanet C.
    Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
    [Abstract] [Full Text] [Related]

  • 14. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors.
    Bönig H, Laws HJ, Wundes A, Verheyen J, Hannen M, Kim YM, Banning U, Nürnberger W, Körholz D.
    Bone Marrow Transplant; 2000 Jul; 26(1):91-6. PubMed ID: 10918410
    [Abstract] [Full Text] [Related]

  • 15. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation.
    Kreijveld E, van der Meer A, Tijssen HJ, Hilbrands LB, Joosten I.
    Transplantation; 2007 Oct 27; 84(8):1045-51. PubMed ID: 17989611
    [Abstract] [Full Text] [Related]

  • 16. Role of KIRs and KIR ligands in hematopoietic transplantation.
    Velardi A.
    Curr Opin Immunol; 2008 Oct 27; 20(5):581-7. PubMed ID: 18675345
    [Abstract] [Full Text] [Related]

  • 17. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP, DA WM, Zhao DD, Wang C, Lu XC, Kang HY, Yan P, Wang FF, Zhu HY, Li HH, Gao CJ, Yu L.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3111-4. PubMed ID: 18269867
    [Abstract] [Full Text] [Related]

  • 18. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
    Zhao XY, Huang XJ, Liu KY, Xu LP, Liu DH.
    Eur J Haematol; 2007 Apr 27; 78(4):338-46. PubMed ID: 17378893
    [Abstract] [Full Text] [Related]

  • 19. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y, Japan Marrow Donor Program.
    Biol Blood Marrow Transplant; 2007 Mar 27; 13(3):315-28. PubMed ID: 17317585
    [Abstract] [Full Text] [Related]

  • 20. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S, Nowak I, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Holowiecka-Goral A, Markiewicz M, Kopera M, Karolczyk A, Kyrcz-Krzemien S, Kusnierczyk P.
    Eur J Haematol; 2009 Oct 27; 83(4):343-56. PubMed ID: 19500138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.